查詢結果分析
來源資料
相關文獻
- The Role of Radiotherapy in the Treatment of Non-Melanomatous Cancers of the Skin
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- 成人低惡性度顱內星狀細胞瘤之術後放射治療
- Prognostic Factors and Results of Radiotherapy for Brain Stem Gliomas
- 第四期鼻咽癌的預後因子
- Palliative Radiotherapy for Synchronous Brain Metastases from Lung Cancer
- Analysis of Prognostic Factors of Oral Cavity Squamous Cell Carcinoma Patients Receiving Surgery
- Postoperative Rodiotherapy in Rectal Cancer: Analysis of Local Control, Surviral and Prognostic Factors
- Clinical Implications of Tumor Volume in Patients with the Base of Tongue Cancer Treated with Definitive Intensity-modulated Radiotherapy Technique
- Treatment Results and Prognostic Factors for Locally Advanced Buccal Cancer
頁籤選單縮合
題 名 | The Role of Radiotherapy in the Treatment of Non-Melanomatous Cancers of the Skin=非黑色素皮膚癌接受放射治療之成果 |
---|---|
作 者 | 岑榮潤; 劉幕台; 蘇志中; 張東浩; 畢祖平; 劉文山; 黃昭源; 王愛義; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 13:1 民95.03 |
頁 次 | 頁1-9 |
分類號 | 415.78 |
關鍵詞 | 放射治療; 非黑色素皮膚癌; 預後因子; Radiotherapy; Nonmelanoma skin cancer; Prognostic factors; |
語 文 | 英文(English) |
中文摘要 | 目的:本文旨在研究非黑色素皮膚癌在接受放射線治療後的結果,並分析影響治療結果的預後因子。 材料與方法:自1994年1月至2004年4月,共有48位病患在彰化基督教醫院診斷為惡性皮膚癌並接受完整放射線治療療程。其中,22位為異性,26位為女性,歲數介於38~94歲(中位數為78歲)。根據2002年AJCC分期系統,第1期至第4期病患人數分別為16例、21例、11例及0例。在病裡診斷方面,27例為鱗狀細胞癌(56.3%),21例為基底細胞癌(43.8%)。腫瘤大小中位數為3公分,腫瘤分佈分別為鼻子(29.2%)、頭皮(25%)、四肢(8.3%)、耳(6.3%)、眼瞼(4.2%)及其他(8.3%)。放射治療為一日一次,總劑量為55~70 Gy(中位數為60 Gy),平均治療時間48天。 結果:追蹤期從6個月至120個月不等(中位數為26個月),此48位病患經放射線治療後的5年整體存活率為56.2%,5年無病存活率37.8%。直至統計期限有8位病患局部復發,有3位遠端轉移。單變數分析結果指出腫瘤期別、組織病理型態及淋巴腺是否轉移此三變項,對整體存活率有顯著之影響(P<0.05)。 結論:本研究結果顯示放射線治療在治療皮膚癌方面有顯著的效果。對於整體存活率、無病存活率、病患耐受度及美觀,也能達到令人滿意的結果。 |
英文摘要 | Purpose: To evaluate the treatment results and analyze the prognostic factors of radiotherapy for skin malignancies. Materials and methods: Form January 1994 to April 2004, 48 patients with malignant skin cancer received a complete course of radiotherapy at Changhua Christian Hospital. There were 22 males and 26 female, between 38 and 94 years old (median: 78 years). The numbers of patients in stage I to IV were 16, 21, 11, and 0, respectively. The subtypes of histology were Squamous cell carcinoma (SCC) in 27 patients (56.3%), and Basal cell carcinoma (BCC) in 21 patients (43.8%). The median tumor size was 3 cm. tumors location was predominantly at nose (29.2%), scalp (25%), facial (18.8%), extremities (8.3%), ear (6.3%), eyelids (4.2%) and others (8.3%). The median radiation dose and total treatment days were 60 Gy and 48 days. Results: The patients were followed up until October 2004. the median duration of follow-up was 26 months (range: 5.8 to 118.8 months). The 5-year overall survival and disease-free survival rate were 56.2% and 37.8%, respectively. Treatment failure included loco-regional relapse (8 patients), and distant metastasis (3 patients). In univariate analysis of variables with log rank test, AJCC stage, histology type and nodal metastasis were the significant prognostic factors (P<0.05) for overall survival. Conclusion: Radiotherapy is effective in treatment of skin cancers. Our data indicated that the overall survival, disease-free survival, cosmetic appearance and patient tolerance were good and feasible. |
本系統中英文摘要資訊取自各篇刊載內容。